These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34474520)

  • 21. Stopping Denosumab.
    Lamy O; Stoll D; Aubry-Rozier B; Rodriguez EG
    Curr Osteoporos Rep; 2019 Feb; 17(1):8-15. PubMed ID: 30659428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?].
    Lamy O; Gonzalez Rodriguez E; Stoll D; Aubry-Rozier B; Livio F
    Praxis (Bern 1994); 2018 Jun; 107(12):649-654. PubMed ID: 29871576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.
    Tsourdi E; Langdahl B; Cohen-Solal M; Aubry-Rozier B; Eriksen EF; Guañabens N; Obermayer-Pietsch B; Ralston SH; Eastell R; Zillikens MC
    Bone; 2017 Dec; 105():11-17. PubMed ID: 28789921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suboptimal medication adherence may favor the progression of vertebral fractures in women with post-menopausal osteoporosis treated with denosumab.
    Betella N; Biamonte E; Matarazzo C; Piccini S; Olivetti R; Cellini M; Lania AG; Mazziotti G
    Minerva Endocrinol; 2020 Sep; 45(3):165-171. PubMed ID: 32186164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be Enough.
    Anastasilakis AD; Trovas G; Balanika A; Polyzos SA; Makras P; Tournis S
    J Clin Densitom; 2021; 24(2):338-340. PubMed ID: 33218880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects and management of denosumab discontinuation.
    Chapurlat R
    Joint Bone Spine; 2018 Oct; 85(5):515-517. PubMed ID: 29317292
    [No Abstract]   [Full Text] [Related]  

  • 27. Magnetic resonance imaging has an advantage over conventional spine X-rays in the evaluation of rebound-associated vertebral fractures following denosumab discontinuation.
    Anastasilakis AD; Evangelatos G; Makras P; Iliopoulos A
    Endocrine; 2020 Sep; 69(3):516-518. PubMed ID: 32441026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of eligibility for denosumab in patients presenting with osteoporotic fractures and renal impairment treated by orthogeriatric service at Middlemore Hospital.
    Kang MY; Besley J; Sun T; Paul S
    N Z Med J; 2020 May; 133(1515):16-24. PubMed ID: 32438373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Denosumab and alendronate treatment in patients with back pain due to fresh osteoporotic vertebral fractures.
    Tetsunaga T; Tetsunaga T; Nishida K; Tanaka M; Sugimoto Y; Takigawa T; Takei Y; Ozaki T
    J Orthop Sci; 2017 Mar; 22(2):230-236. PubMed ID: 28087216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.
    Meier C; Uebelhart B; Aubry-Rozier B; Birkhäuser M; Bischoff-Ferrari HA; Frey D; Kressig RW; Lamy O; Lippuner K; Stute P; Suhm N; Ferrari S
    Swiss Med Wkly; 2017; 147():w14484. PubMed ID: 28871570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multiple vertebral fractures after denosumab discontinuation].
    Tjelum L; Eiken P
    Ugeskr Laeger; 2018 Nov; 180(45):. PubMed ID: 30404716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?
    Anastasilakis AD; Tournis S; Yavropoulou MP; Polyzos SA; Makras P
    Calcif Tissue Int; 2018 Jul; 103(1):107-108. PubMed ID: 29492590
    [No Abstract]   [Full Text] [Related]  

  • 33. Underestimation of Vertebral Fractures After Denosumab Discontinuation.
    Lamy O; Gonzalez-Rodriguez E
    J Bone Miner Res; 2018 Mar; 33(3):547. PubMed ID: 29393984
    [No Abstract]   [Full Text] [Related]  

  • 34. Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review.
    Elbers LPB; Raterman HG; Lems WF
    Drugs; 2021 Sep; 81(14):1645-1655. PubMed ID: 34524681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Status quo of osteoporosis treatment in Japan disclosed by the National Database of Health Insurance Claims and Specific Health Checkups: too late in treatment initiation and too few in treated patients?
    Kamata Y; Minota S
    Arch Osteoporos; 2019 Jul; 14(1):84. PubMed ID: 31367957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Denosumab for Reducing Risk of Fractures in Postmenopausal Women.
    Song P; Zehtabchi S
    Am Fam Physician; 2019 May; 99(9):Online. PubMed ID: 31038897
    [No Abstract]   [Full Text] [Related]  

  • 37. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vertebral Fractures Following Denosumab Discontinuation in Patients with Prolonged Exposure to Bisphosphonates.
    Tripto-Shkolnik L; Rouach V; Marcus Y; Rotman-Pikielny P; Benbassat C; Vered I
    Calcif Tissue Int; 2018 Jul; 103(1):44-49. PubMed ID: 29396698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CLINICAL EVALUATION OF COST EFFICACY OF DRUGS FOR TREATMENT OF OSTEOPOROSIS: A META-ANALYSIS.
    Albert SG; Reddy S
    Endocr Pract; 2017 Jul; 23(7):841-856. PubMed ID: 28448754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension.
    Cummings SR; Ferrari S; Eastell R; Gilchrist N; Jensen JB; McClung M; Roux C; Törring O; Valter I; Wang AT; Brown JP
    J Bone Miner Res; 2018 Feb; 33(2):190-198. PubMed ID: 29105841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.